Nanopac 100mg (Paclitaxel ( Protein -bound Particles ) Vials) 100mg

Nanopac 100mg contains paclitaxel protein-bound particles in vials for injection. This formulation is used for cancer therapy and is stored at 15-25°C. It is a chemotherapy medication designed to target rapidly dividing cells. Suitable for patients requiring paclitaxel-based treatment.

Strength

100mg

Pack Size

Storage

15-25°

Manufacturer / TM Owner

Getwell Pharmaceutical

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nanopac 100mg is primarily used in cancer treatment, including breast cancer, lung cancer, and pancreatic cancer. It works by interfering with the growth of cancer cells. This medication is often prescribed when other treatments are not effective. It may also be used for other conditions as determined by a healthcare provider.

Side Effects

Nanopac 100mg may cause side effects such as nausea, hair loss, or fatigue. Some patients experience numbness or tingling in the hands or feet. These effects vary by individual and are typically temporary. Regular monitoring by a healthcare professional is recommended during treatment.

Precautions & Warnings

Store Nanopac 100mg vials at 15-25°C and protect from light. Keep out of reach of children and pets. Do not use if the vial is damaged or the solution is discolored. Handle with care to avoid contamination. Always follow the storage instructions provided with the medication.

Avoid Interactions

Nanopac 100mg may interact with other medications, including certain antibiotics, antifungals, or blood thinners. Alcohol and grapefruit products may also affect how the drug works. Always inform your healthcare provider about all medications and supplements you are taking. Some interactions may require dose adjustments.

Frequently Asked Questions

Nanopac 100mg is used to treat certain types of cancer, such as breast, lung, and pancreatic cancer.

Store the vials at 15-25°C and protect them from light. Avoid freezing or refrigeration.

Common side effects may include nausea, hair loss, or fatigue. These effects vary by individual.

Yes, Nanopac 100mg contains paclitaxel, which is a chemotherapy medication.

Inform your doctor about all medications, supplements, and health conditions you have before starting treatment.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.